Molecule News and Research

RSS

US Government supports Kinoxis Therapeutics to end opioid addiction

Kinoxis Therapeutics has been awarded a grant for a potential of up to $US4.6 million ($6.8 million) under the USA National Institutes of Health Helping to End Addiction Long-Term, or the NIH HEAL Initiative.

30 Sep 2019

Study uncovers molecule linking weight gain to gut bacteria

UT Southwestern researchers have found a key driver of the crosstalk that helps synchronize the absorption of nutrients in the gut with the rhythms of the Earth's day-night light cycle.

27 Sep 2019

How tau protein causes brain damage in Alzheimer’s disease

Researches have described a new technique to find out how Alzheimer's disease (AD) affects nerve cells.

27 Sep 2019

Cancer Research Institute declares 2019 recipients of top scientific and philanthropic awards

The Cancer Research Institute (CRI), a nonprofit organization dedicated to advancing the discovery and development of powerful immunotherapies for all forms of cancer, has announced the 2019 recipients of its highest scientific and philanthropic awards.

27 Sep 2019

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment avenue for patients with non-small cell lung cancer and kidney cancer.

26 Sep 2019

Children's of Alabama using cold sore virus to fight pediatric brain cancer

Children's of Alabama is home to one of the most exciting studies underway in pediatric cancer: evaluating the use of a cold sore virus to treat children with progressive malignant brain tumors.

26 Sep 2019

Researchers develop superior method to track Alzheimer’s pathology in single neuronal cells

University of Warwick researchers have developed a superior method to describe the very earliest effects that Alzheimer's Disease proteins have on the properties of brain cells.

26 Sep 2019

Russian researchers come up with faster method to discover antibiotics

Russian biochemists have identified a promising new class of antibiotics. Having studied over 125,000 molecules, they found that 2-pyrazol-1-yl-thiazole derivatives exhibit antibacterial properties.

26 Sep 2019

Johns Hopkins researchers identify new way to lower blood pressure in obese patients

There's no question that as body weight increases, so too does blood pressure. Now, in a study of mice, Johns Hopkins researchers have revealed exactly which molecules are likely responsible for the link between obesity and blood pressure.

From Johns Hopkins Medicine 26 Sep 2019

Investigational drug may offer new treatment option for patients with lung and kidney cancer

26 Sep 2019

UCLA researchers identify new drug delivery pathway to stop tumor growth

Researchers at the UCLA Jonsson Comprehensive Cancer Center have identified a new drug delivery pathway that may help stop tumor growth and keep cancer from coming back in mice.

25 Sep 2019

UAB researchers find key role for IgG autoantibodies in IgA nephropathy

The most common form of the kidney disease called glomerulonephritis is IgA nephropathy.

24 Sep 2019

TUM researchers reveal how chaperones detect immature immune signaling proteins

The cells of our immune system constantly communicate with one another by exchanging complex protein molecules.

24 Sep 2019

Researchers map and activate bacterial 'immune defense system'

With the aid of highly advanced microscopes and synchrotron sources, researchers from the University of Copenhagen have gained seminal insight into how bacteria function as defense mechanisms against attacks from other bacteria and viruses.

24 Sep 2019

Bath researchers identify promising prostate cancer drug candidates

Cancer researchers from the University of Bath have identified some promising drug candidates by using high-throughput screening methods to test tens of thousands of molecules.

24 Sep 2019

Researchers make breakthrough in understanding enzymes that assemble the antibiotic enacyloxin

One of the WHO's three critical priority pathogens, Acinetobacter baumannii, for which new antibiotics are urgently needed is one step closer to being tackled, as researchers from the Department of Chemistry - University of Warwick have made a breakthrough in understanding the enzymes that assemble the antibiotic enacyloxin.

24 Sep 2019

Molecule News and Research

US Government supports Kinoxis Therapeutics to end opioid addiction

Study uncovers molecule linking weight gain to gut bacteria

How tau protein causes brain damage in Alzheimer’s disease

Cancer Research Institute declares 2019 recipients of top scientific and philanthropic awards

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Children's of Alabama using cold sore virus to fight pediatric brain cancer

Researchers develop superior method to track Alzheimer’s pathology in single neuronal cells

Russian researchers come up with faster method to discover antibiotics

Johns Hopkins researchers identify new way to lower blood pressure in obese patients

Investigational drug may offer new treatment option for patients with lung and kidney cancer

UCLA researchers identify new drug delivery pathway to stop tumor growth

UAB researchers find key role for IgG autoantibodies in IgA nephropathy

TUM researchers reveal how chaperones detect immature immune signaling proteins

Researchers map and activate bacterial 'immune defense system'

Bath researchers identify promising prostate cancer drug candidates

Researchers make breakthrough in understanding enzymes that assemble the antibiotic enacyloxin

Research: Protein complex represents a new metabolic target for liver cancer

Newly synthesized anticancer compound can block cancer signaling mechanism

Researchers discover how bacterial enzyme removes inflammation-causing meat carbohydrates

Scientists develop method to reactivate tumor suppressor genes 'silenced' by cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News